[1]
“PATHOLOGICAL OUTCOME OF HER2/NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY”, FMHR, vol. 3, no. 7, pp. 1552–1558, Sep. 2025, Accessed: Aug. 12, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1887